Medicaid medication access problems and increased psychiatric hospital and emergency care.

[1]  M. Rubio‐Stipec,et al.  First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients. , 2010, The Journal of clinical psychiatry.

[2]  M. Rubio‐Stipec,et al.  Part D and dually eligible patients with mental illness: medication access problems and use of intensive services. , 2009, Psychiatric services.

[3]  M. Rubio‐Stipec,et al.  Part D and Dual-Eligibles with Mental Illness: Problems Accessing Medications and Use of Intensive Mental Health Services , 2009 .

[4]  S. Crystal,et al.  Medicaid prescription drug policies and medication access and continuity: findings from ten states. , 2009, Psychiatric services.

[5]  Y. Zhang,et al.  Effects of prior authorization on medication discontinuation among Medicaid beneficiaries with bipolar disorder. , 2009, Psychiatric services.

[6]  Bryan R Cote,et al.  Impact of therapeutic switching in long-term care. , 2008, The American journal of managed care.

[7]  K. Levit,et al.  Future funding for mental health and substance abuse: increasing burdens for the public sector. , 2008, Health affairs.

[8]  Fang Zhang,et al.  Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change. , 2008, Health affairs.

[9]  S. Soumerai,et al.  A longitudinal study of medication nonadherence and hospitalization risk in schizophrenia. , 2008, The Journal of clinical psychiatry.

[10]  K. Levit,et al.  Mental health treatment expenditure trends, 1986-2003. , 2007, Psychiatric services.

[11]  Dana P Goldman,et al.  Prescription drug cost sharing: associations with medication and medical utilization and spending and health. , 2007, JAMA.

[12]  Philip S. Wang,et al.  Medicaid's prior authorization program and access to atypical antipsychotic medications. , 2007, Health affairs.

[13]  J. Newhouse,et al.  Coverage and prior authorization of psychotropic drugs under Medicare Part D. , 2007, Psychiatric services.

[14]  R. Diamond,et al.  The Relationship of Antipsychotic Medication Class and Adherence with Treatment Outcomes and Costs for Florida Medicaid Beneficiaries with Schizophrenia , 2007, Administration and Policy in Mental Health and Mental Health Services Research.

[15]  Nancy H. Covell,et al.  Effectiveness of switching antipsychotic medications. , 2006, The American journal of psychiatry.

[16]  Erin Fries Taylor,et al.  The struggle to provide community-based care to low-income people with serious mental illnesses. , 2006, Health affairs.

[17]  M. Hostetter,et al.  Using clinical evidence to manage pharmacy benefits: experiences of six states. , 2006, Issue brief.

[18]  A. Lippman.  Adherence to medication. , 2005, The New England journal of medicine.

[19]  Alexander L. Miller,et al.  Defining and assessing adherence to oral antipsychotics: a review of the literature. , 2005, Schizophrenia bulletin.

[20]  J. Lieberman,et al.  Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. , 2005, The New England journal of medicine.

[21]  C. Camargo,et al.  Trends in U.S. emergency department visits for mental health conditions, 1992 to 2001. , 2005, Psychiatric services.

[22]  Olga V. Demler,et al.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.

[23]  C. Koyanagi,et al.  Medicaid policies to contain psychiatric drug costs. , 2005, Health affairs.

[24]  C. Bowden,et al.  Pharmacotherapy for bipolar depression: an economic assessment , 2004, Expert opinion on pharmacotherapy.

[25]  R. Scheffler,et al.  Comparison of psychiatrists and psychologists in clinical practice. , 2002, Psychiatric services.

[26]  J A Hanley,et al.  Adverse events associated with prescription drug cost-sharing among poor and elderly persons. , 2001, JAMA.

[27]  D. Mechanic,et al.  Utilization of specialty mental health care among persons with severe mental illness: the roles of demographics, need, insurance, and risk. , 2000, Health services research.

[28]  R. D'Agostino.  Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .

[29]  S. Soumerai,et al.  Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia , 1994 .

[30]  D M Steinwachs,et al.  Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Client Survey. , 1998, Schizophrenia bulletin.